Kobo Biotech not a 'Large Corporate' as per SEBI norms

Kobo Biotech Limited has officially confirmed that as of March 31, 2026, the company does not fall under the category of a 'Large Corporate (LC)'. This determination is based on the framework and applicability criteria outlined in SEBI Circulars SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, and SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021. This intimation means Kobo Biotech is not subject to the specific disclosure requirements related to fund-raising by issuance of debt securities applicable to large entities.